{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:11:48Z","timestamp":1754154708222,"version":"3.41.2"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research Applied Research Collaboration North West Coast"},{"name":"Applied Health Research and Care North West Coast"},{"name":"Wolfson Centre for Personalised Medicine"},{"DOI":"10.13039\/501100021117","name":"Liverpool University Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening reactions that cause blistering of the skin and mucous membranes. Survivors can experience long-term physical and psychological complications. The \u2018My SJS Passport\u2019 was co-produced by the Patient and Public Involvement group and research team at the Wolfson Centre for Personalised Medicine to improve the care and experiences of survivors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of the study was to implement the \u2018My SJS Passport\u2019 in a real-world setting for evaluation by those with lived experience of SJS\/TEN. The objectives were to assess participants' perceptions of its acceptability and utility when used during appointments with healthcare professionals and to explore perceptions of its value and potential barriers to implementation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A proof-of-concept study to evaluate the acceptability and usability of the passport using a mixed-methods approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A questionnaire was completed by 19 (86%) women and 3 (14%) men (patient, family member, guardian or carer), and 11 of 22 participated in focus groups. The findings suggest the passport is a valuable communication tool, as it acted as the \u2018patient\u2019s voice\u2019 and helped in validating the diagnosis with healthcare professionals, family and friends.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The study provides the first formal evaluation of the passport and showed that the tool is acceptable, functional and of benefit to the user. Minor barriers to implementation were identified, largely due to the COVID-19 pandemic and, to a lesser extent, the passport design. There is no comparable tool in use; thus, based on these preliminary findings, it is thought that the passport has a valuable role in supporting this underserved population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llaf088","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T14:07:56Z","timestamp":1741442876000},"page":"1542-1550","source":"Crossref","is-referenced-by-count":0,"title":["Co-production of the \u2018My SJS Passport\u2019 to support survivors of Stevens\u2013Johnson syndrome post-diagnosis and beyond: a proof-of-concept study"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6089-9631","authenticated-orcid":false,"given":"Anita","family":"Hanson","sequence":"first","affiliation":[{"name":"Liverpool University Hospitals NHS Foundation Trust , Liverpool ,","place":["UK"]},{"name":"Wolfson Centre for Personalised Medicine (WCPM), Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Hampson","sequence":"additional","affiliation":[{"name":"Liverpool University Hospitals NHS Foundation Trust , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Evely","sequence":"additional","affiliation":[{"name":"University Hospitals Plymouth NHS Trust , Plymouth ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Hill","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Personalised Medicine (WCPM), Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Elsdon","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Personalised Medicine (WCPM), Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thermutis\u00a0Nadier","family":"Lawson","sequence":"additional","affiliation":[{"name":"SJS Awareness \u00a0","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Burns","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Personalised Medicine (WCPM), Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F","family":"Carr","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Personalised Medicine (WCPM), Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Thompson","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Personalised Medicine (WCPM), Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Downing","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Applied Research Collaboration North West Coast (NIHR ARC NWC), University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7534-7266","authenticated-orcid":false,"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[{"name":"Wolfson Centre for Personalised Medicine (WCPM), Department of Pharmacology and Therapeutics, University of Liverpool , Liverpool ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"2025072412171144700_llaf088-B1","doi-asserted-by":"crossref","first-page":"949520","DOI":"10.3389\/fmed.2022.949520","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review of PubMed\/MEDLINE case reports from 1980 to 2020","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025072412171144700_llaf088-B2","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.bjps.2016.01.034","article-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"69","author":"Creamer","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"2025072412171144700_llaf088-B3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bjd.17841","article-title":"British Association of Dermatologists guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in children and young people, 2018","volume":"181","author":"McPherson","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025072412171144700_llaf088-B4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.burns.2015.03.012","article-title":"Complications of Stevens-Johnson syndrome beyond the eye and skin","volume":"42","author":"Saeed","year":"2016","journal-title":"Burns"},{"key":"2025072412171144700_llaf088-B5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025072412171144700_llaf088-B6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamadermatol.2021.1136","article-title":"Long-term physical and psychological outcomes of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"157","author":"Hoffman","year":"2021","journal-title":"JAMA Dermatol"},{"key":"2025072412171144700_llaf088-B7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11588460-000000000-00000","article-title":"Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK","volume":"34","author":"Butt","year":"2011","journal-title":"Drug Safety"},{"key":"2025072412171144700_llaf088-B8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.BCR.0000150215.78220.79","article-title":"The 2004 Carl A. Moyer award: late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center","volume":"26","author":"Haber","year":"2005","journal-title":"J Burn Care Rehab"},{"key":"2025072412171144700_llaf088-B9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025072412171144700_llaf088-B10","doi-asserted-by":"crossref","first-page":"1213889","DOI":"10.3389\/fmed.2023.1213889","article-title":"Updates in SJS\/TEN: collaboration, innovation, and community","volume":"10","author":"Marks","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2025072412171144700_llaf088-B11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharm Stat"},{"key":"2025072412171144700_llaf088-B12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jclinepi.2011.07.011","article-title":"The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency","volume":"65","author":"Sim","year":"2012","journal-title":"J Clin Epidemiol"},{"volume-title":"Qualitative Research Practice: A Guide for Social Science Students and Researchers","year":"2013","author":"Ritchie","key":"2025072412171144700_llaf088-B13"},{"key":"2025072412171144700_llaf088-B14","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-137-28127-2","volume-title":"Nursing Research: Principles, Process and Issues","author":"Parahoo","year":"2014"},{"volume-title":"Basics of Qualitative Research","year":"1990","author":"Strauss","key":"2025072412171144700_llaf088-B15"},{"key":"2025072412171144700_llaf088-B16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s40264-013-0070-6","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis: are drug dictionaries correctly informing physicians regarding the risk?","volume":"36","author":"Haddad","year":"2013","journal-title":"Drug Safety"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf088\/62350233\/llaf088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/8\/1542\/62350233\/llaf088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/8\/1542\/62350233\/llaf088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T16:17:23Z","timestamp":1753373843000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/8\/1542\/8064588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,3,8]]},"published-print":{"date-parts":[[2025,7,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf088","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,3,8]]}}}